Skip to main content

Aleksandra (Ola) Howell

photo of Aleksandra (Ola) HowellOla Howell is a pharmacist, advanced clinical practitioner and clinical leader with over 15 years of experience across community pharmacy, primary, secondary, and tertiary care, as well as health innovation. She is skilled in developing and implementing new pathways and services and has a strong focus on quality improvement and research. Ola regularly collaborates with commissioners and has co-authored several guidelines and pathways. Her previous team's work on improving the identification of severe asthma in primary care was recognised as a finalist at the 2023 HSJ Awards.
Currently, Ola is an NIHR Doctoral Fellow at the University of Oxford, where she is researching the use of COPD ‘rescue packs’ in primary care in England. She is also a guest lecturer at the University of Bath and a mentor to pharmacists, supporting career progression and building confidence.
In addition to her role on the PCRS Policy Forum, Ola is a member of the British Thoracic Society COPD Specialist Advisory Group and the Health Innovation Network Respiratory Working Group, contributing to national initiatives in respiratory care.

  • Aleksandra (Ola) Howell

    Bands:
    A Less than 2% of gross annual income
    B Between 2% and 10% of gross annual income
    C Any payment between 10% and 20% of gross annual income
    D Any payment over 20% of your gross annual income

    All interests declared are for the previous calendar year

    Section 1: Paid Work / Personal Income

    A. Employments (including partnerships)

    I am an employee, paid director and / or partner of an organisation
    Any NHS organisation (including GP practice): None
    Private healthcare provider: None
    University: Band D
    Other commercial organisation, including pharmaceutical companies, device manufacturers & agencies: None
    Not-for-profit organisation(s): None

    B. Other paid positions / work

    I do not receive personal income from the pharmaceutical industry or any healthcare related organisation(s) (except any employee salary or partnership interest declared in Section A)

    C. Other income

    I do not receive any other income (e.g. share dividends from commercial healthcare or tobacco companies)

    D. Other personal benefits

    I have received hospitality/travel grants from pharmaceutical companies to attend conferences/meetings

    Section 2: Unpaid Work

    A. Trusteeships / Directorships (unpaid)

    I do not hold any trusteeships/directorships in any healthcare related organisation or tobacco manufacturer

    B. Other unpaid / voluntary work

    Do you hold any other significant positions that may create a conflicting interest to PCRS? No

    Section 3: Shareholdings in relevant companies

    Pharmaceutical Companies

    I have shareholdings in the tobacco industry or pharmaceutical or other healthcare company
    Abbott: None
    AstraZeneca UK: Band A
    BI: None
    Cheisi: None
    Cipla: None
    Glenmark: None
    GSK: None
    Johnson & Johnson: None
    Lupin: None
    Napp: None
    Novartis: None
    Orion: None
    Pfizer: Band A
    Sandoz: None
    Sanofi: None
    Teva: None
    Tobacco Manufacturer: None
    Viatris: None
    Other pharmaceutical companies: None
    Other device or equipment manufacturer: None
    Private healthcare provider (e.g. Virgin): None
    Pharmaceutical industry agency: None
    Medical/healthcare publisher (e.g. Pulse, MGP): None
    Other commercial organisation(s): None

    Section 4: Other Non-personal Interests

    Does your practice, CCG or Department (or any organisation that you have a band D interest in or a trustee/directorship with) receive any fees/grants/benefits in kind worth £2500 or more, for which you have direct responsibility, from any commercial heal: No

    Section 5: Interests of Spouses / Long Term Partners and Children

    Does your spouse/long term partner or children have any relevant employments, paid work or significant unpaid work in any healthcare related organisation or the tobacco industry?: No